125 related articles for article (PubMed ID: 14514693)
1. Protonation states of methionine aminopeptidase and their relevance for inhibitor binding and catalytic activity.
Klein CD; Schiffmann R; Folkers G; Piana S; Röthlisberger U
J Biol Chem; 2003 Nov; 278(48):47862-7. PubMed ID: 14514693
[TBL] [Abstract][Full Text] [Related]
2. Understanding the selectivity of fumagillin for the methionine aminopeptidase type II.
Klein CD; Folkers G
Oncol Res; 2003; 13(12):513-20. PubMed ID: 12899241
[TBL] [Abstract][Full Text] [Related]
3. The anti-angiogenic agent fumagillin covalently modifies a conserved active-site histidine in the Escherichia coli methionine aminopeptidase.
Lowther WT; McMillen DA; Orville AM; Matthews BW
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12153-7. PubMed ID: 9770455
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the methionine aminopeptidases.
Lowther WT; Matthews BW
Biochim Biophys Acta; 2000 Mar; 1477(1-2):157-67. PubMed ID: 10708856
[TBL] [Abstract][Full Text] [Related]
5. Proteomics-based target identification: bengamides as a new class of methionine aminopeptidase inhibitors.
Towbin H; Bair KW; DeCaprio JA; Eck MJ; Kim S; Kinder FR; Morollo A; Mueller DR; Schindler P; Song HK; van Oostrum J; Versace RW; Voshol H; Wood J; Zabludoff S; Phillips PE
J Biol Chem; 2003 Dec; 278(52):52964-71. PubMed ID: 14534293
[TBL] [Abstract][Full Text] [Related]
6. Structure of human methionine aminopeptidase-2 complexed with fumagillin.
Liu S; Widom J; Kemp CW; Crews CM; Clardy J
Science; 1998 Nov; 282(5392):1324-7. PubMed ID: 9812898
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling and calculation of the cobalt cluster charges of the Encephazlitozoon cuniculi methionine aminopeptidase, a potential target for drug design.
Bontems F; le Floch P; Duffieux F; Biderre C; Peyret P; Lallemand JY
Biophys Chem; 2003 Aug; 105(1):29-43. PubMed ID: 12932577
[TBL] [Abstract][Full Text] [Related]
8. Interactions of Streptomyces griseus aminopeptidase with amino acid reaction products and their implications toward a catalytic mechanism.
Gilboa R; Spungin-Bialik A; Wohlfahrt G; Schomburg D; Blumberg S; Shoham G
Proteins; 2001 Sep; 44(4):490-504. PubMed ID: 11484227
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the metal binding site in methionine aminopeptidase by density functional theory.
Jørgensen AT; Norrby PO; Liljefors T
J Comput Aided Mol Des; 2002 Mar; 16(3):167-79. PubMed ID: 12363216
[TBL] [Abstract][Full Text] [Related]
10. Catalysis and inhibition of Mycobacterium tuberculosis methionine aminopeptidase.
Lu JP; Chai SC; Ye QZ
J Med Chem; 2010 Feb; 53(3):1329-37. PubMed ID: 20038112
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the active site and insight into the binding mode of the anti-angiogenesis agent fumagillin to the manganese(II)-loaded methionyl aminopeptidase from Escherichia coli.
D'souza VM; Brown RS; Bennett B; Holz RC
J Biol Inorg Chem; 2005 Jan; 10(1):41-50. PubMed ID: 15578241
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli methionine aminopeptidase: implications of crystallographic analyses of the native, mutant, and inhibited enzymes for the mechanism of catalysis.
Lowther WT; Orville AM; Madden DT; Lim S; Rich DH; Matthews BW
Biochemistry; 1999 Jun; 38(24):7678-88. PubMed ID: 10387007
[TBL] [Abstract][Full Text] [Related]
13. Structure of a microsporidian methionine aminopeptidase type 2 complexed with fumagillin and TNP-470.
Alvarado JJ; Nemkal A; Sauder JM; Russell M; Akiyoshi DE; Shi W; Almo SC; Weiss LM
Mol Biochem Parasitol; 2009 Dec; 168(2):158-67. PubMed ID: 19660503
[TBL] [Abstract][Full Text] [Related]
14. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2.
Sin N; Meng L; Wang MQ; Wen JJ; Bornmann WG; Crews CM
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6099-103. PubMed ID: 9177176
[TBL] [Abstract][Full Text] [Related]
15. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
16. Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase.
Addlagatta A; Matthews BW
Protein Sci; 2006 Aug; 15(8):1842-8. PubMed ID: 16823043
[TBL] [Abstract][Full Text] [Related]
17. Structural analysis of inhibition of E. coli methionine aminopeptidase: implication of loop adaptability in selective inhibition of bacterial enzymes.
Ma ZQ; Xie SX; Huang QQ; Nan FJ; Hurley TD; Ye QZ
BMC Struct Biol; 2007 Dec; 7():84. PubMed ID: 18093325
[TBL] [Abstract][Full Text] [Related]
18. Methionine aminopeptidases as potential targets for treatment of gastrointestinal cancers and other tumours.
Mauriz JL; Martín-Renedo J; García-Palomo A; Tuñón MJ; González-Gallego J
Curr Drug Targets; 2010 Nov; 11(11):1439-57. PubMed ID: 20583970
[TBL] [Abstract][Full Text] [Related]
19. Binding of alpha-hydroxy-beta-amino acid inhibitors to methionine aminopeptidase. The performance of two types of scoring functions.
Jørgensen AT; Sørensen MD; Björkling F; Liljefors T
J Comput Aided Mol Des; 2003; 17(5-6):383-97. PubMed ID: 14635729
[TBL] [Abstract][Full Text] [Related]
20. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
Zhou G; Tsai CW; Liu JO
J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
